This research study is studying a combination therapy as a possible treatment for recurrent
glioblastoma (GBM), a brain tumor that is growing or progressing despite earlier treatment.
The names of the study interventions involved in this study are/is:
- Pembrolizumab
- Olaparib
- Temozolomide (Temodar)